Government admits ‘remote risk’ that drug manufacturers may withdraw supply following proposed tax increase
A proposed tax rise, from 24.4% to 27.5%, for manufacturers signed up to the statutory tax scheme for branded medicines would cause a "remote and limited risk" of companies withdrawing products from the UK market, the government has said.…
